Motus GI Holdings bouncing off fresh 52-week low on Positive Clinical Data News

(24/7 MARKET NEWS) – Motus GI Holdings, Inc., (NASDAQ: MOTS) is trading at $1.87, up $0.27 (+16.88%), on 2,234,807 premarket shares traded. It reached this morning’s pre-market high of $2.23 after announcing that three abstracts featuring clinical data on the Pure-Vu EVS were presented in poster sessions at the American College of Gastroenterology (ACG) 2022 Annual Scientific Meeting, in Charlotte, North Carolina, October 21 to 26, 2022. The three abstracts will be published on the Motus GI Website:

On Friday it traded as low as $1.53. Its 52-week range is $1.53 to $15.996, with the $2 level looking like a key inflection point.

24/7 MARKET NEWS, INC Disclaimer

24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.

Please go to or for further information.


Signup today for free and be the first to get notified of breaking news.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.


Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Add New Playlist